1. Ohno S, Ohguchi M, Hirose S, Matsuda H, Wakisaka A, Aizawa M. Close association of HLA-Bw51 with Behçet's disease. Arch Ophthalmol. 1982; 100:1455–8.
2. Mendoza-Pinto C, García-Carrasco M, Jiménez-Hernández M, Jiménez Hernández C, Riebeling-Navarro C, Nava Zavala A, et al. Etiopathogenesis of Behçet's disease. Autoimmun Rev. 2010; 9:241–5.
3. Kaya Tİ. Genetics of Behçet's disease. Patholog Res Int. 2012; 2012; 912589.
4. Xavier JM, Shafiee NM, Ghaderi F, Rosa A, Abdollahi BS, Nadji A, et al. Association of mitochondrial polymorphism m.709G> A with Behçet's disease. Ann Rheum Dis. 2011; 70:1514–6.
5. International Study Group for Behçet's Disease. Criteria for diagnosis of Behçet's disease. Lancet. 1990; 335:1078–80.
6. Kussmaul L, Hirst J. The mechanism of superoxide production by NADH:ubiquinone oxidoreductase (complex I) from bovine heart mitochondria. Proc Natl Acad Sci U S A. 2006; 103:7607–12.
Article
7. Thomas AW, Edwards A, Sherratt EJ, Majid A, Gagg J, Alcolado JC. Molecular scanning of candidate mitochondrial tRNA genes in type 2 (non-insulin dependent) diabetes mellitus. J Med Genet. 1996; 33:253–5.
Article
8. Maassen JA, 't Hart LM, Janssen GM, Reiling E, Romijn JA, Lemkes HH. Mitochondrial diabetes and its lessons for common Type 2 diabetes. Biochem Soc Trans. 2006; 34:819–23.
Article
9. De Vivo DC. The expanding clinical spectrum of mitochondrial diseases. Brain Dev. 1993; 15:1–22.
Article
10. Nakahira K, Haspel JA, Rathinam VA, Lee SJ, Dolinay T, Lam HC, et al. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat Immunol. 2011; 12:222–30.
Article
11. Zhou R, Yazdi AS, Menu P, Tschopp J. A role for mitochondria in NLRP3 inflammasome activation. Nature. 2011; 469:221–5.
Article
12. Lee HY, Yoo JE, Park MJ, Chung U, Shin KJ. Mitochondrial DNA control region sequences in Koreans: identification of useful variable sites and phylogenetic analysis for mtDNA data quality control. Int J Legal Med. 2006; 120:5–14.
Article